Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beam Fiel ointment for mild to moderate fungal skin infections
ISRCTN87982460Phase 2Completed
- Sponsor
- Beam Hela Osu
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Beam Fiel ointment in skin mycoses, sponsored by Beam Hela Osu. Primary endpoint: Reduction of skin lesion. Started Dec 2025; status: completed.
02
Drugs
Beam Fiel ointment
03
Conditions
skin mycoses
Beyond the preview
Go deeper on ISRCTN87982460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN87982460.